Arkus develops machine learning algorithms for genetic diagnostics that analyze genomic data to provide precise genetic insights. This technology enables early disease detection and the formulation of personalized treatment plans, improving healthcare outcomes.
Funding
$50K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The increasing complexity of genomic data and the need for personalized treatment plans require advanced analytical tools that can efficiently process and interpret genetic information. Current methods for clinical decision support often lack the ability to fully leverage the potential of AI, leading to inefficiencies and potential for errors in healthcare delivery.
Solution
Arkus AI develops Arkus Core, an agentic AI platform designed to power personalized medicine across care, research, and drug discovery. The platform enables innovators to create and scale modular, intelligent AI agents that address specific challenges within the personalized medicine ecosystem. Arkus Core facilitates the integration of AI into clinical workflows, accelerating insights for pharmaceutical and biotech companies, and empowering health-tech companies to build and deploy custom AI agents. By providing a foundation for AI agent development, Arkus AI aims to transform healthcare delivery through safer, higher-quality, and more efficient solutions.
Target Audience
Arkus AI targets healthcare providers seeking to add trusted AI to clinical workflows, pharmaceutical and biotech companies aiming to accelerate discovery, and health-tech companies looking to build and scale custom AI agents.
Features
- Agentic Intelligence: Modular and composable AI agents for targeted solutions.
- Interoperable Platform: Seamless integration with existing healthcare systems.
- Clinical Decision Support: AI agents that streamline and digitize key tasks, from patient pedigree gathering to genetic testing and risk assessment.
- AI-powered Workflow Tool: Supports the creation of detailed hereditary cancer risk profiles.
- Regulatory-Aware Design: Built with compliance pathways from the start.
- Integration with Large Language Models: Combines deep learning with symbolic, knowledge-based methods.